The global osteoarthritis therapeutics market size is calculated at USD 9.91 billion in 2024 and is expected to reach around USD 24.34 billion by 2034, growing at a solid CAGR of 9.4% from 2024 to ...

In this randomized controlled trial, total hip replacement (THR) was superior to resistance training in improving hip pain ...

According to the National Institute for Health and Care Excellence (NICE), around 10 million people in the UK are living with ...

Doron Therapeutics, a clinical-stage biotech company focusing on degenerative musculoskeletal conditions, today announced it ...

This improves joint function and movement, which can help restore your ability to participate in regular activities.Prognosis ...

A new study published in the journal of PLOS One found that increased addition of sugar elevated the risk of osteoarthritis, ...

If you have osteoarthritis, you know how much joint pain can affect your daily life. Osteoarthritis is the most common type of arthritis, afflicting 33 million U.S. adults, according to the Centers ...

Shared genetic factors may drive both osteoarthritis and cardiovascular disease, suggesting a common genetic basis that ...

Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), ...

Cutting-edge research presented at ACR Convergence 2024 unveils Nav1.7 sodium channels as a promising target to treat ...

Aching knees, hips and hands are nothing new to those with Osteoarthritis, but a new study in Oklahoma focuses on the ...

Hip osteoarthritis is a degenerative disease of the hip joint that progresses in four characteristic stages. With each stage of osteoarthritis of the hip, symptoms such as pain, stiffness, and loss of ...